Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enteral erythromycin estolate + intravenous metoclopramide vs intravenous metoclopramide alone in mechanically ventilated patients with enteral feeding intolerance
TCTR20171004004Phase 4Completed
- Sponsor
- Siam University
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of erythromycin, metoclopramide in enteral feeding intolerance (EFI), Gastrointestinal Dysmotility, sponsored by Siam University. Started Feb 2018; status: completed.
02
Drugs
erythromycinmetoclopramide
03
Conditions
enteral feeding intolerance (EFI)Gastrointestinal Dysmotility
Beyond the preview
Go deeper on TCTR20171004004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20171004004.